Skip to main content Accessibility help

Are we diagnosing too many people with coeliac disease?

  • Imran Aziz (a1) and David S. Sanders (a1)


This review will try to address the question of whether we are diagnosing too many people with coeliac disease. The key reasons for diagnosing coeliac disease may be that it is a common condition affecting up to 1% of the adult population. Delays in diagnosis are common. The average time delay reported by Coeliac UK (National Medical Patient Charity), for patients with symptoms prior to the diagnosis being made is 13 years. For every adult case detected, it is estimated that there are eight cases not detected. Patients with coeliac disease have an associated morbidity and mortality. In addition, quality of life studies suggest that the majority of patients benefit from a gluten-free diet (GFD). Furthermore, the GFD reduces or alleviates the risk of the associated complications. All of these facts could even be used to support the argument for screening! However, conversely the tests for coeliac disease are not 100% sensitive and specific. In addition, we do not know whether patients with milder symptoms will derive less benefit from treatment and are at less risk of complications. Furthermore, evidence presented in this review suggests that actual outcomes for screening studies in an adult population have revealed poor uptake and subsequently difficulties with adherence. What little published data that are available also infers that individuals recognised through screening programmes could have been detected if carefully questioned for symptoms. There is evidence to suggest that diagnosing celiac disease is cost-effective and that the diagnostic costs are offset by reduced medical expenditures, reduced hospital and general practice attendances, but this view depends on the population prevalence of coeliac disease. We believe on the basis of the evidence presented in this review that we are not diagnosing too many adults with coeliac disease. However, the authors consider case-finding with a low threshold for serological testing to be the optimal approach. If you look for coeliac disease you will find it.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Are we diagnosing too many people with coeliac disease?
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Are we diagnosing too many people with coeliac disease?
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Are we diagnosing too many people with coeliac disease?
      Available formats


Corresponding author

* Corresponding author: Dr Imran Aziz, fax +44 114 2712692, email


Hide All
1. West, J, Logan, RF, Hill, PG et al. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52, 960965.
2. Catassi, C, Kryszak, D, Bhatti, B et al. (2010) Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 42, 530538.
3. Lohi, S, Mustalahti, K, Kaukinen, K et al. (2007) Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26, 12171225.
4. van Heel, DA & West, J (2006) Recent advances in coeliac disease. Gut 55, 10371046.
5. Chorzelski, TP, Sulej, J, Tchorzewska, H et al. (1983) IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 420, 325334.
6. Leffler, DA & Schuppan, D (2010) Update on serologic testing in celiac disease. Am J Gastroenterol 105, 25202524.
7. National Institute for Health and Clinical Excellence (2009) Coeliac Disease: Recognition and Assessment of Coeliac Disease. London: NICE. Available at:
8. Richey, R, Howdle, P, Shaw, E et al. (2009) Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. Br Med J 338, b1684.
9. Toftedal, P, Nielsen, C, Madsen, JT et al. (2010) Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med 48, 685691.
10. James, MW & Scott, BB (2000) Endomysial antibody in the diagnosis and management of coeliac disease. Postgrad Med J 76, 466468.
11. Lewis, NR & Scott, BB (2006) Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 24, 4754.
12. Dieterich, W, Ehnis, T, Bauer, M et al. (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3, 797801.
13. Hill, ID (2005) What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 128, Suppl 1, S25S32.
14. Naiyer, AJ, Hernandez, L, Ciaccio, EJ et al. (2009) Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 43, 225232.
15. Wong, RC, Wilson, RJ, Steele, RH et al. (2002) A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 55, 488494.
16. Rostami, K, Kerckhaert, J, Tiemessen, R et al. (1999) Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94, 888894.
17. Rostom, A, Dubé, C, Cranney, A et al. (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128, Suppl 1, S38S46.
18. Walker, MM, Murray, JA, Ronkainen, J et al. (2010) Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 139, 112119.
19. Lewis, NR & Scott, BB (2010) Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 31, 7381.
20. Basso, D, Guariso, G, Fogar, P et al. (2009) Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 55, 150157.
21. Kurppa, K, Lindfors, K, Collin, P et al. (2011) Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 45, 673678.
22. Niveloni, S, Sugai, E, Cabanne, A et al. (2007) Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 53, 21862192.
23. Volta, U, Granito, A, Fiorini, E et al. (2008) Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 53, 15821588.
24. Volta, U, Granito, A, Parisi, C et al. (2010) Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 44, 186190.
25. Ferre-López, S, Ribes-Koninckx, C, Genzor, C et al. (2004) Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease. Clin Gastroenterol Hepatol 2, 480484.
26. Baldas, V, Tommasini, A, Trevisiol, C et al. (2000) Development of a novel rapid non-invasive screening test for coeliac disease. Gut 47, 628631.
27. Raivio, T, Kaukinen, K, Nemes, E et al. (2006) Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 24, 147154.
28. Raivio, T, Korponay-Szabó, I, Collin, P et al. (2007) Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies. Dig Liver Dis 39, 10571063.
29. Raivio, T, Korponay-Szabó, IR, Paajanen, T et al. (2008) Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays. J Pediatr Gastroenterol Nutr 47, 562567.
30. Korponay-Szabó, IR, Raivio, T, Laurila, K et al. (2005) Coeliac disease case finding and diet monitoring by point-of-care testing. Aliment Pharmacol Ther 22, 729737.
31. Korponay-Szabó, IR, Szabados, K, Pusztai, J et al. (2007) Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. Br Med J 335, 12441247.
32. Hopper, AD, Cross, SS, Hurlstone, DP et al. (2007) Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. Br Med J 334, 729.
33. Tursi, A, Brandimarte, G & Giorgetti, GM (2001) Sorbitol H2-breath test versus anti-endomysium antibodies for the diagnosis of subclinical/silent coeliac disease. Scand J Gastroenterol 36, 11701172.
34. Tursi, A, Brandimarte, G & Giorgetti, GM (2003) Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36, 219221.
35. Tursi, A, Elisei, W, Giorgetti, GM et al. (2009) Complications in celiac disease under gluten-free diet. Dig Dis Sci 54, 21752182.
36. Ludvigsson, JF, Montgomery, SM, Ekbom, A et al. (2009) Small-intestinal histopathology and mortality risk in celiac disease. JAMA 302, 11711178.
37. Lohi, S, Mäki, M, Rissanen, H et al. (2009) Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 41, 508515.
38. Johnston, SD, Watson, RG, McMillan, SA et al. (1998) Coeliac disease detected by screening is not silent – simply unrecognized. Q J Med 91, 853860.
39. Rubio-Tapia, A, Kyle, RA, Kaplan, EL et al. (2009) Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137, 8893.
40. Metzger, MH, Heier, M, Mäki, M et al. (2006) Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989–1998. Eur J Epidemiol 21, 359365.
41. Godfrey, JD, Brantner, TL, Brinjikji, W et al. (2010) Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 139, 763769.
42. Ciacci, C, Cirillo, M, Auriemma, G et al. (1996) Celiac disease and pregnancy outcome. Am J Gastroenterol 91, 718722.
43. Ludvigsson, JF, Montgomery, SM & Ekbom, A (2005) Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 129, 454463.
44. Greco, L, Veneziano, A, Di Donato, L et al. (2004) Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 53, 149151.
45. Meyer, D, Stavropolous, S, Diamond, B et al. (2001) Osteoporosis in a north American adult population with celiac disease. Am J Gastroenterol 96, 112119.
46. Corazza, GR, Di Sario, A, Cecchetti, L et al. (1996) Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 18, 525530.
47. Cellier, C, Flobert, C, Cormier, C et al. (2000) Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 355, 806.
48. West, J, Logan, RF, Card, TR et al. (2003) Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 125, 429436.
49. Card, TR, West, J & Holmes, GK (2004) Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20, 769775.
50. West, J, Logan, RF, Smith, CJ et al. (2004) Malignancy and mortality in people with coeliac disease: population based cohort study. Br Med J 329, 716719.
51. Logan, RF (2009) Malignancy in unrecognised coeliac disease: a nail in the coffin for mass screening? Gut 58, 618619.
52. Lohi, S, Mäki, M, Montonen, J et al. (2009) Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut 58, 643647.
53. Corrao, G, Corazza, GR, Bagnardi, V et al. (2001) Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358, 356361.
54. Leffler, DA, Edwards-George, J, Dennis, M et al. (2008) Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci 53, 15731581.
55. Nachman, F, Mauriño, E, Vázquez, H et al. (2009) Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 41, 1525.
56. Hall, NJ, Rubin, G & Charnock, A (2009) Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 30, 315330.
57. Shamir, R, Hernell, O & Leshno, M (2006) Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making 26, 282293.
58. Mein, SM & Ladabaum, U (2004) Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 19, 11991210.
59. Dorn, SD & Matchar, DB (2008) Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 53, 680688.
60. Green, PH, Neugut, AI, Naiyer, AJ et al. (2008) Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 40, 218228.
61. Long, KH, Rubio-Tapia, A, Wagie, AE et al. (2010) The economics of coeliac disease: a population-based study. Aliment Pharmacol Ther 32, 261269.
62. Gray, AM & Papanicolas, IN (2010) Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res 10, 105.
63. Hopper, AD, Hadjivassiliou, M, Butt, S et al. (2007) Adult coeliac disease. Br Med J 335, 558562.
64. Catassi, C, Rätsch, IM, Fabiani, E et al. (1994) Coeliac disease in the year 2000: exploring the iceberg. Lancet 343, 200203.
65. Simell, S, Hoppu, S, Hekkala, A et al. (2007) Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 102, 20262035.
66. Mariné, M, Fernández-Bañares, F, Alsina, M et al. (2009) Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 15, 13311338.
67. Hin, H, Bird, G, Fisher, P et al. (1999) Coeliac disease in primary care: case finding study. Br Med J 318, 164167.
68. Sanders, DS, Patel, D, Stephenson, TJ et al. (2003) A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15, 407413.


Are we diagnosing too many people with coeliac disease?

  • Imran Aziz (a1) and David S. Sanders (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed